Physician profile
Patrick J Welch
NPI 1417146283
$7,792.82
in general payments reported to CMS, 2019-2025
24 companies · $2,293 in 2025
The $2,293 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $672 · 2020: $1,714 · 2021: $588 · 2022: $544 · 2023: $1,056 · 2024: $925 · 2025: $2,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,134 · Travel and Lodging: $1,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,134.08 |
| Travel and Lodging | $1,140.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,742.73 | 2019-2025 | Aveir, Jot Dx, Ensite |
| Boston Scientific Corporation | $1,635.02 | 2019-2025 | Watchman Flx, Rhythmia Mapping System, Watchman Access System |
| Medtronic, INC. | $1,044.33 | 2021-2025 | Selectsecure, Micra, Cobalt Dr Mri Surescan |
| Impulse Dynamics (USA) INC. | $401.12 | 2022-2025 | Optimizer, Optimizer |
| Janssen Pharmaceuticals, INC | $388.22 | 2019-2024 | Xarelto |
| Cardiva Medical, INC. | $372.71 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs |
| Pfizer INC. | $350.09 | 2019-2022 | |
| Biosense Webster, INC. | $295.81 | 2021-2025 | Carto 3 |
| Biotronik INC. | $291.10 | 2022-2025 | Acticor 7 Vr-T Dx, Solia, Amvia Edge |
| Medtronic Vascular, INC. | $264.97 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $225.96 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $209.40 | 2019-2024 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $203.79 | 2022-2025 | Lifevest |
| Atricure, INC. | $91.04 | 2019 | |
| Ethicon US, LLC | $57.30 | 2023-2025 | Echelon; Endopath, Stratafix, Dermabond Prineo |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $51.09 | 2019-2020 | |
| Abiomed | $26.54 | 2023 | Impella |
| Irhythm Technologies, INC. | $25.12 | 2022-2023 | Zio Xt Patch |
| Inspire Medical Systems, INC. | $24.04 | 2025 | Inspire |
| Elutia, INC. | $23.19 | 2025 | Ecm Patch,Pouch |
| Stryker Corporation | $19.41 | 2025 | Flowtriever |
| Trisalus Life Sciences, INC. | $18.22 | 2019 | |
| Kerecis Limited | $16.32 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Cardiovascular Systems INC. | $15.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.